29 related articles for article (PubMed ID: 30989895)
21. [Mining and discovery for active components of "Coptidis Rhizome-Magnoliae Officinalis Cortex" based on network pharmacology].
Wu HN; Yu GH; Zhao FZ; Jia XB; Feng L; Shi XH
Zhongguo Zhong Yao Za Zhi; 2019 Feb; 44(4):803-810. PubMed ID: 30989895
[TBL] [Abstract][Full Text] [Related]
22. [Predictive analysis of quality markers of Coptidis Rhizoma based on network pharmacology and multivariate statistical analysis].
Li CX; He QY; Liu J; Wang YC; Xue BB; Tang Q; Liu H; Liu EW; Chen XP
Zhongguo Zhong Yao Za Zhi; 2021 Jun; 46(11):2718-2727. PubMed ID: 34296568
[TBL] [Abstract][Full Text] [Related]
23. [Geo-herbalism study of Magnoliae Officinalis Cortex].
Xue ZZ; Zhang RX; Yang B
Zhongguo Zhong Yao Za Zhi; 2019 Sep; 44(17):3601-3607. PubMed ID: 31602929
[TBL] [Abstract][Full Text] [Related]
24. Berberine and Coptidis Rhizoma as potential anticancer agents: Recent updates and future perspectives.
Wang N; Tan HY; Li L; Yuen MF; Feng Y
J Ethnopharmacol; 2015 Dec; 176():35-48. PubMed ID: 26494507
[TBL] [Abstract][Full Text] [Related]
25. Safety and Toxicology of Magnolol and Honokiol.
Sarrica A; Kirika N; Romeo M; Salmona M; Diomede L
Planta Med; 2018 Nov; 84(16):1151-1164. PubMed ID: 29925102
[No Abstract] [Full Text] [Related]
26. Pharmacology, Toxicity, Bioavailability, and Formulation of Magnolol: An Update.
Lin Y; Li Y; Zeng Y; Tian B; Qu X; Yuan Q; Song Y
Front Pharmacol; 2021; 12():632767. PubMed ID: 33815113
[TBL] [Abstract][Full Text] [Related]
27.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
28.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
29.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Previous] [New Search]
